Literature DB >> 23625574

Nongenomic actions of progesterone and 17β-estradiol on the chloride conductance of skeletal muscle.

James A Burge1, Michael G Hanna, Stephanie Schorge.   

Abstract

INTRODUCTION: Myotonia congenita, caused by mutations in ClC-1, tends to be more severe in men and is often exacerbated by pregnancy.
METHODS: We performed whole-cell patch clamp of mouse muscle chloride currents in the absence/presence of 100 μM progesterone or 17β-estradiol.
RESULTS: 100 μM progesterone rapidly and reversibly shifted the ClC-1 activation curve of mouse skeletal muscle (V50 changed from -52.6 ± 9.3 to +35.5 ± 6.7; P < 0.01) and markedly reduced chloride currents at depolarized potentials. 17β-estradiol at the same concentration had a similar but smaller effect (V50 change from -57.2 ± 7.6 to -40.5 ± 9.8; P < 0.05). 1 μM progesterone produced no significant effect.
CONCLUSIONS: Although the data support the existence of a nongenomic mechanism in mammalian skeletal muscle through which sex hormones at high concentration can rapidly modulate ClC-1, the influence of hormones on muscle excitability in vivo remains an open question.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  chloride channel; excitability; myotonia congenita; sex hormones; skeletal muscle

Mesh:

Substances:

Year:  2013        PMID: 23625574     DOI: 10.1002/mus.23887

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  2 in total

1.  In vitro analysis of splice site mutations in the CLCN1 gene using the minigene assay.

Authors:  Gianna Ulzi; Valeria A Sansone; Francesca Magri; Stefania Corti; Nereo Bresolin; Giacomo P Comi; Sabrina Lucchiari
Journal:  Mol Biol Rep       Date:  2014-01-23       Impact factor: 2.316

2.  Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia.

Authors:  Lorenzo Maggi; Sabrina Ravaglia; Alessandro Farinato; Raffaella Brugnoni; Concetta Altamura; Paola Imbrici; Diana Conte Camerino; Alessandro Padovani; Renato Mantegazza; Pia Bernasconi; Jean-François Desaphy; Massimiliano Filosto
Journal:  Neurogenetics       Date:  2017-10-09       Impact factor: 2.660

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.